<DOC>
	<DOC>NCT02108119</DOC>
	<brief_summary>To demonstrate benefit of a probiotic product in adults with irritable bowel syndrome.</brief_summary>
	<brief_title>The Effect of Probiotics on Symptoms and Intestinal Flora in Patients With Irritable Bowel Syndrome</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Irritable Bowel Syndrome</mesh_term>
	<criteria>Willing and able to provide informed consent Age ≥18 and ≤70 years at Visit 1 IBS according to the Rome III criteria A score on abdominal pain NRS ≥3 and ≤6 at least two days a week measured the weeks before Visit 2 (baseline) IBSSSS ≥75 and ≤300 at Visit 2 (baseline) Ability and willingness to understand and comply with the study procedures Known intolerance or allergy to milk products (protein or lactose) or gluten History of alcohol or substance abuse six months prior to screening Known Hepatitis B or C or Human Immunodeficiency Virus (HIV) 1 or 2 Female patients: currently pregnant or breastfeeding or intending to become pregnant during the study Abnormal results of the screening laboratory tests clinically relevant for study participation, as judged by the Investigator Other gastrointestinal disease(s) that explains the patient's symptoms, as judged by the Investigator Other severe disease(s) such as malignancy, severe coronary disease, kidney disease or neurological disease, as judged by the Investigator Symptoms indicating other severe disease(s) such as gastrointestinal bleeding, loss of weight or fever, as judged by the Investigator Severe psychiatric disease as judged by the Investigator Lack of suitability for participation in the study for any reason as judged by the Investigator Use of other probiotic products from Visit 1 and throughout the study. Consumption of antibiotic drugs 1 month prior to screening and throughout the study. Consumption of drugs on a regular basis which could interfere with symptom evaluation as judged by the Investigator.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>May 2015</verification_date>
</DOC>